Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cypher Genomics logo — Unlocking the potential of human genome data through automat...

Cypher Genomics

Unlocking the potential of human genome data through automated interpretation for clinical labs and pharmaceutical research.

Founded 2011 United States San Diego, United States 2 employees Non Equity Assistance Analytics, Biotechnology +1

General Information

Company Name Cypher Genomics
Founded Year 2011
Location United States San Diego, United States +1
Employees 2
Industries Analytics, Biotechnology, Health Care
Funding Stage Non Equity Assistance
Social

Get notified when Cypher Genomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cypher Genomics

Cypher Genomics is a biotech startup that focuses on genome informatics, providing automated software solutions for the interpretation of human genomes. Their platform is designed to cater to clinical labs, pharmaceutical companies, and population genomics initiatives, unlocking the potential of human genome data for various applications. Founded in 2011 by Ashley Van Zeeland and based in La Jolla, California, Cypher Genomics has carved out a niche in the industry. Their innovative approach allows clinical laboratories to customize the sensitivity and specificity of Cypher Genomics' profiles, facilitating the development of molecular tests for diagnosis and prognosis. Moreover, pharmaceutical companies can leverage the platform to identify biomarkers using whole genome sequence data in early-stage drug development studies. This versatility makes Cypher Genomics a valuable asset in both clinical and research settings. The recent non-equity assistance investment at 01 November 2016 by EvoNexus signifies continued interest and support in Cypher Genomics' endeavors. Furthermore, the acquisition of Cypher Genomics by Human Longevity underscores the company's potential and the attractiveness of its technology in the market. In summary, Cypher Genomics is at the forefront of genome informatics, offering automated interpretation solutions that have garnered attention from investors and industry players alike. With its focus on clinical applications and pharmaceutical research, the company is well-positioned to make significant contributions to the evolving landscape of genomics and biotechnology.

Taxonomy: Genome Informatics, Genomic Interpretation, Clinical Laboratories, Molecular Tests, Pharmaceutical Research, Biomarker Discovery, Whole Genome Sequencing, Diagnostic Tools, Prognostic Tools, Population Genomics, Automated Software Solutions, Human Longevity, Drug Development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance •••••• 1
Investor
01 Nov 2016
Non Equity Assistance •••••• 1
Investor
01 May 2012

Cypher Genomics Alternatives & Competitors

Cypher Genomics vs
Personal Genomics
Personal Genomics Italy

Personal Genomics mette la genomica a disposizione della clinica con le più recenti tecnologie di se...

30 employees
Health Care, Health and Wellness
Cypher Genomics vs
iBinom
iBinom

Aiming to get a foothold in the emerging clinical next-gen sequencing market iBinom launched a simpl...

Seed
1 employees
Big Data, Biotechnology
Cypher Genomics vs
InterpretOmics
InterpretOmics

InterpretOmics InterpretOmics is an integrated genomics company specializing in genome-scale data...

Angel
Analytics, Biotechnology

FAQ About Cypher Genomics

Unlocking the potential of human genome data through automated interpretation for clinical labs and pharmaceutical research.
Cypher Genomics was founded in 2011.
Cypher Genomics is headquartered in San Diego, United States.
Cypher Genomics operates in the following industries: Analytics, Biotechnology, Health Care.
Cypher Genomics has approximately 2 employees.
Cypher Genomics has completed 2 funding rounds. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Cypher Genomics include Personal Genomics, iBinom, InterpretOmics, KSQ Therapeutics, Inc., JMDNA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cypher Genomics and Personal Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cypher Genomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes